These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34488801)

  • 1. The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China.
    Lee VC; Yao J; Zhang W
    Global Health; 2021 Sep; 17(1):101. PubMed ID: 34488801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.
    Jung YL; Hwang J; Yoo HS
    Global Health; 2020 Sep; 16(1):80. PubMed ID: 32912258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting public health research in BRICS through a multinational public health prize fund.
    Campbell M
    Indian J Med Ethics; 2014; 11(1):38-41. PubMed ID: 24509109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
    Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Emerging Markets on the Pharmaceutical Industry.
    Tannoury M; Attieh Z
    Curr Ther Res Clin Exp; 2017; 86():19-22. PubMed ID: 29234483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring why global health needs are unmet by research efforts: the potential influences of geography, industry and publication incentives.
    Yegros-Yegros A; van de Klippe W; Abad-Garcia MF; Rafols I
    Health Res Policy Syst; 2020 May; 18(1):47. PubMed ID: 32414373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development.
    Manner CK; Graef KM; Dent J
    Trop Med Infect Dis; 2019 Mar; 4(1):. PubMed ID: 30917506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.
    Richeldi L; Rubin AS; Avdeev S; Udwadia ZF; Xu ZJ
    BMC Med; 2015 Sep; 13():237. PubMed ID: 26399999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development.
    Cole CB; Trolle S; Edwards DJ
    Health Res Policy Syst; 2018 Aug; 16(1):73. PubMed ID: 30071858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Global Fund financing on health governance in Brazil.
    Gómez EJ; Atun R
    Global Health; 2012 Jul; 8():25. PubMed ID: 22799635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global health research partnerships in the context of the Sustainable Development Goals (SDGs).
    Addo-Atuah J; Senhaji-Tomza B; Ray D; Basu P; Loh FE; Owusu-Daaku F
    Res Social Adm Pharm; 2020 Nov; 16(11):1614-1618. PubMed ID: 32893133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTELLECTUAL PROPERTY IN THE TWENTY-FIRST CENTURY: WILL THE DEVELOPING COUNTRIES LEAD OR FOLLOW?
    Reichman JH
    Houst Law Rev; 2009 Jan; 46(4):1115-1185. PubMed ID: 21423816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis.
    McMullan P; Ajay VS; Srinivas R; Bhalla S; Prabhakaran D; Banerjee A
    Glob Health Action; 2018; 11(1):1434935. PubMed ID: 29495950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children.
    CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management.
    Rodwin VG; Fabre G; Ayoub RF
    Int J Health Policy Manag; 2018 Mar; 7(3):201-206. PubMed ID: 29524948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partnership and Participation-A Social Network Analysis of the 2017 Global Fund Application Process in the Democratic Republic of the Congo and Uganda.
    Shelley KD; Kamya C; Mpanya G; Mulongo S; Nagasha SN; Beylerian E; Duber HC; Hernandez B; Osterman A; Phillips DE; Shearer JC;
    Ann Glob Health; 2020 Nov; 86(1):140. PubMed ID: 33200071
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.